TapImmune Inc (NASDAQ:TPIV)

3.69
Delayed Data
As of May 18
 +0.2101 / +6.04%
Today’s Change
2.58
Today|||52-Week Range
4.41
-5.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
 
Operating ExpensesGross Income0.000.000.000.00--
General Expenses3.4M6.2M8.5M11.7M
 
 
 
 
 
Research And Development189.0K1.7M3.8M5.3M
 
 
 
 
 
Total Operating Expenses3.4M6.2M8.5M11.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-6.2M-8.5M-11.7M
 
 
 
 
 
Extraordinary Credit581.000.005.9M497.9K
 
 
 
 
Extraordinary Charge-26.9M-27.9M-135.6K0.00
 
 
 
 
Interest Expense On Debt575.5K10.9K0.00--
 
 
 
Other Expenses-53.0K-23.9K1.8K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.9M-34.1M-2.5M-11.0M
 
 
 
 
 
Net Income-30.9M-34.1M-2.5M-11.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.3M3.7M6.9M9.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.3M3.7M7.4M9.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$24.00-$9.36-$0.72-$1.16
 
 
 
 
 
EPS Diluted-$24.00-$9.36-$0.72-$1.16